Clinical Trial: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Topical Tacrolimus 0.1% Ointment for Treatment of Cutaneous Crohn's Disease
Brief Summary: An assessment of the efficacy of topical tacrolimus in the treatment of cutaneous crohns disease
Detailed Summary:
Sponsor: University of Aberdeen
Current Primary Outcome: Assessment of standardised digital photography by three independent assessors following the Physicians' Global Severity Scale before and after treatment [ Time Frame: At 12 weeks of treatment, optionally extended to 52 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Global Self Assessment [ Time Frame: 12 weeks, optionally extended to 52 weeks ]
- Perineal Disease Activity Index [ Time Frame: 12 weeks, optionally extended to 52 weeks ]
Original Secondary Outcome: Same as current
Information By: University of Aberdeen
Dates:
Date Received: November 2, 2010
Date Started:
Date Completion:
Last Updated: November 2, 2010
Last Verified: November 2010